Zaynich achieves over 97% efficacy in clinical study for meropenem-resistant gram-negative pathogens
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Silica is a proven and highly effective anti-caking agent that has been used for decades
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
H.coagulans is, unlike other general lactobacillus, characterized by spore formation, giving it resistance to acid and heat
The approval further adds to Biocon’s portfolio of complex drug products
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Subscribe To Our Newsletter & Stay Updated